During the past decade, PTC- Skaraborg conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "PTC- Skaraborg" are "Obesity" (1 trials) and "Stress Urinary Incontinence" (1 trials). Many other conditions were trialed in "PTC- Skaraborg" in a lesser frequency.

Most popular intervention types in "PTC- Skaraborg" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "JNJ-64565111 Dose Level 1" (1 trials), "JNJ-64565111 Dose Level 2" (1 trials), "JNJ-64565111 Dose Level 3" (1 trials), "Liraglutide" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "PTC- Skaraborg" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "PTC- Skaraborg". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in PTC- Skaraborg, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in PTC- Skaraborg, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".